# Knockdown of Rab9 Recovers Defective Morphological Differentiation Induced by Chemical ER Stress Inducer or PMD-Associated PLP1 Mutant Protein in FBD-102b Cells

**Authors:** Nana Fukushima, Yuki Miyamoto, Junji Yamauchi

PMC · DOI: 10.3390/pathophysiology31030032 · 2024-08-26

## TL;DR

This study shows that reducing Rab9 activity can reverse abnormal cell shape changes caused by ER stress or PLP1 mutations in oligodendroglial cells, which may help treat diseases like HLD1.

## Contribution

The novel finding is that Rab9 knockdown recovers defective morphological differentiation in FBD-102b cells under ER stress or PLP1 mutation conditions.

## Key findings

- Rab9 knockdown increases membrane extensions and differentiation marker expression in FBD-102b cells.
- Rab9 knockdown recovers ER stress-induced morphological defects and marker protein levels.
- Similar recovery is observed with DTT and HLD1-associated PLP1 mutant protein.

## Abstract

Small GTP-binding proteins of the Rab family regulate intracellular vesicle trafficking across many aspects of the transport system. Among these, Rab9 is recognized for its role in controlling the transport system not only around the trans-Golgi network but also around the late endosome. However, the specific functions across different cell types and tissues remain unclear. Here, for the first time, we report that Rab9 negatively regulates morphological changes in the FBD-102b cell line, an oligodendroglial precursor cell line undergoing morphological differentiation. The knockdown of Rab9 led to an increase in cell shape alterations characterized by widespread membrane extensions. These changes were accompanied by increased expression levels of oligodendroglial cell differentiation and myelination marker proteins. Notably, the knockdown of Rab9 was capable of recovering defective cell morphological changes induced by tunicamycin, an inducer of endoplasmic reticulum (ER) stress, which is one of the major causes of oligodendroglial cell diseases such as Pelizaeus–Merzbacher disease (PMD, currently known as hypomyelinating leukodystrophy type 1 [HLD1]). In addition, Rab9 knockdown recovered levels of ER stress marker proteins and differentiation markers. Similar results were obtained in the cases of dithiothreitol (DTT), another chemical ER stress inducer, as well as HLD1-associated proteolipid protein 1 (PLP1) mutant protein. These results indicate a unique role for Rab9 in oligodendroglial cell morphological changes, suggesting its potential as a therapeutic target for mitigating diseases such as HLD1 at the molecular and cellular levels.

## Linked entities

- **Genes:** RAB9A (RAB9A, member RAS oncogene family) [NCBI Gene 9367], PLP1 (proteolipid protein 1) [NCBI Gene 5354]
- **Proteins:** RAB9A (RAB9A, member RAS oncogene family), PLP1 (proteolipid protein 1)
- **Chemicals:** dithiothreitol (PubChem CID 19001)
- **Diseases:** Pelizaeus–Merzbacher disease (MONDO:0010714)

## Full-text entities

- **Genes:** PLP1 (proteolipid protein 1) [NCBI Gene 5354] {aka GPM6C, HLD1, MMPL, PLP, PLP/DM20, PMD}, RAB9A (RAB9A, member RAS oncogene family) [NCBI Gene 9367] {aka RAB9}
- **Diseases:** PMD (MESH:D020371), oligodendroglial cell diseases (MESH:D009081)
- **Chemicals:** DTT (MESH:D004229), tunicamycin (MESH:D014415)
- **Cell lines:** FBD-102b — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_C6DV)

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11417737/full.md

---
Source: https://tomesphere.com/paper/PMC11417737